4.6 Article

Fingolimod Attenuates Splenocyte-Induced Demyelination in Cerebellar Slice Cultures

Journal

PLOS ONE
Volume 9, Issue 6, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0099444

Keywords

-

Funding

  1. Trinity College Dublin Ireland
  2. Novartis Pharma Basel Switerland

Ask authors/readers for more resources

The family of sphingosine-1-phosphate receptors (S1PRs) is G-protein-coupled, comprised of subtypes S1PR1-S1PR5 and activated by the endogenous ligand S1P. The phosphorylated version of Fingolimod (pFTY720), an oral therapy for multiple sclerosis (MS), induces S1PR1 internalisation in T cells, subsequent insensitivity to S1P gradients and sequestering of these cells within lymphoid organs, thus limiting immune response. S1PRs are also expressed in neuronal and glial cells where pFTY720 is suggested to directly protect against lysolecithin-induced deficits in myelination state in organotypic cerebellar slices. Of note, the effect of pFTY720 on immune cells already migrated into the CNS, prior to treatment, has not been well established. We have previously found that organotypic slice cultures do contain immune cells, which, in principle, could also be regulated by pFTY720 to maintain levels of myelin. Here, a mouse organotypic cerebellar slice and splenocyte co-culture model was thus used to investigate the effects of pFTY720 on splenocyte-induced demyelination. Spleen cells isolated from myelin oligodendrocyte glycoprotein immunised mice (MOG-splenocytes) or from 2D2 transgenic mice (2D2splenocytes) both induced demyelination when co-cultured with mouse organotypic cerebellar slices, to a similar extent as lysolecithin. As expected, in vivo treatment of MOG-immunised mice with FTY720 inhibited demyelination induced by MOG-splenocytes. Importantly, in vitro treatment of MOG- and 2D2-splenocytes with pFTY720 also attenuated demyelination caused by these cells. In addition, while in vitro treatment of 2D2-splenocytes with pFTY720 did not alter cell phenotype, pFTY720 inhibited the release of the pro-inflammatory cytokines such as interferon gamma (IFN gamma) and interleukin 6 (IL6) from these cells. This work suggests that treatment of splenocytes by pFTY720 attenuates demyelination and reduces pro-inflammatory cytokine release, which likely contributes to enhanced myelination state induced by pFTY720 in organotypic cerebellar slices.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Pharmacology & Pharmacy

The Role of the Oxysterol/EBI2 Pathway in the Immune and Central Nervous Systems

Aleksandra Rutkowska, Kumlesh K. Dev, Andreas W. Sailer

CURRENT DRUG TARGETS (2016)

Review Pharmacology & Pharmacy

In vitro and ex vivo models of multiple sclerosis

Martin Madill, Denise Fitzgerald, Kara E. O'Connell, Kumlesh K. Dev, Sanbing Shen, Una FitzGerald

DRUG DISCOVERY TODAY (2016)

Article Immunology

Fractalkine shedding is mediated by p38 and the ADAM10 protease under pro-inflammatory conditions in human astrocytes

Sinead A. O'Sullivan, Fabrizio Gasparini, Anis K. Mir, Kumlesh K. Dev

JOURNAL OF NEUROINFLAMMATION (2016)

Article Neurosciences

Demyelination induced by oxidative stress is regulated by sphingosine 1-phosphate receptors

Sinead A. O'Sullivan, Maria Velasco-Estevez, Kumlesh K. Dev

Article Immunology

The chemokine fractalkine (CX3CL1) attenuates H2O2-induced demyelination in cerebellar slices

Sinead A. O'Sullivan, Kumlesh K. Dev

JOURNAL OF NEUROINFLAMMATION (2017)

Article Immunology

EBI2 receptor regulates myelin development and inhibits LPC-induced demyelination

Aleksandra Rutkowska, Andreas W. Sailer, Kumlesh K. Dev

JOURNAL OF NEUROINFLAMMATION (2017)

Review Neurosciences

Sphingosine-1-phosphate receptor therapies: Advances in clinical trials for CNS-related diseases

Sinead O'Sullivan, Kumlesh K. Dev

NEUROPHARMACOLOGY (2017)

Editorial Material Neurosciences

Lipid sensing G protein-coupled receptors in the CNS

K. K. Dev, A. J. Irving

NEUROPHARMACOLOGY (2017)

Article Neurosciences

A novel modelling mechanism of PAEL receptor and GABARAPL2 interaction involved in Parkinson's disease

Priyanka Dutta, Leila Dargahi, Kara E. O'Connell, Ashini Bolia, Banu Ozkan, Andreas W. Sailer, Kumlesh K. Dev

NEUROSCIENCE LETTERS (2018)

Article Multidisciplinary Sciences

Phospholipase A2 is involved in galactosylsphingosine-induced astrocyte toxicity, neuronal damage and demyelination

Cedric Misslin, Maria Velasco-Estevez, Marie Albert, Sinead A. O'Sullivan, Kumlesh K. Dev

PLOS ONE (2017)

Article Neurosciences

Piezo1 regulates calcium oscillations and cytokine release from astrocytes

Maria Velasco-Estevez, Sara O. Rolle, Myrthe Mampay, Kumlesh K. Dev, Graham K. Sheridan

Article Neurosciences

Inhibition of Piezo1 attenuates demyelination in the central nervous system

Maria Velasco-Estevez, Kamal K. E. Gadalla, Nuria Linan-Barba, Stuart Cobb, Kumlesh K. Dev, Graham K. Sheridan

Article Neurosciences

Fingolimod Rescues Demyelination in a Mouse Model of Krabbe's Disease

Sibylle Bechet, Sinead A. O'Sullivan, Justin Yssel, Steven G. Fagan, Kumlesh K. Dev

JOURNAL OF NEUROSCIENCE (2020)

Article Biochemistry & Molecular Biology

The Effects of Antipsychotics in Experimental Models of Krabbe Disease

Kapil Sharma, Kumlesh K. Dev

Summary: The role of altered myelin in the onset and development of schizophrenia and changes in myelin due to antipsychotics remains unclear. However, this study suggests that antipsychotics directly regulate glial cell dysfunction and exert a protective effect on myelin loss. These findings may have implications for the potential use of antipsychotics in Krabbe disease.

BIOMEDICINES (2023)

Article Clinical Neurology

Olaparib Attenuates Demyelination and Neuroinflammation in an Organotypic Slice Culture Model of Metachromatic Leukodystrophy

Marianna Mekhaeil, Melissa Jane Conroy, Kumlesh Kumar Dev

Summary: Metachromatic leukodystrophy (MLD) is a severe genetic leukodystrophy characterized by deficits in the arylsulfatase A gene (ARSA) and accumulation of sulfatide. In an ex vivo cerebellar slice culture model, sulfatide was found to induce demyelination through PARP-1 activation, oligodendrocyte loss, inflammation, and gliosis. Treatment with the PARP-1 inhibitor Olaparib attenuated sulfatide-induced effects, indicating its potential therapeutic utility in rare demyelinating diseases.

NEUROTHERAPEUTICS (2023)

No Data Available